Rowland Charles A Jr
Insider CIK 1383292 · IDIX Director · VTAE Director · BIND Director · BPMC Director · VKTX Director · NBRV Director · NBRV Director · GBIO Director · ORTX Director · VPHM VP, Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 1,500 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 2,500 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 1,920 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 6,000 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 5,200 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 4,246 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 3,000 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | U Tender | 2026-02-09 | 2026-02-09 | 53,475 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 20,400 | — | $0 | 20,400 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2026-01-02 | 2026-01-05 | 3,150 | — | $0 | 33,150 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2025-10-27 | 2025-10-28 | 16,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2025-10-27 | 2025-10-28 | 22,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2025-10-27 | 2025-10-28 | 22,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2025-10-27 | 2025-10-28 | 16,000 | $4.48 | $71.7K | 46,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2025-10-27 | 2025-10-28 | 22,000 | $5.80 | $127.6K | 68,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2025-10-27 | 2025-10-28 | 22,000 | $4.88 | $107.4K | 90,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2025-10-27 | 2025-10-28 | 60,000 | $35.57 | $2.13M | 30,000 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2025-06-04 | 2025-06-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2025-01-02 | 2025-01-06 | 18,800 | — | $0 | 18,800 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2024-06-06 | 2024-06-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2024-01-24 | 2024-01-24 | 105,000 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2024-01-24 | 2024-01-24 | 46,000 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer | 2024-01-24 | 2024-01-24 | 12,294 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 32,000 | — | $0 | 32,000 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2023-12-04 | 2023-12-05 | 150,000 | $1.50 | $225.0K | 534,757 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2023-12-01 | 2023-12-05 | 192,960 | $1.31 | $252.8K | 384,757 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2023-06-14 | 2023-06-16 | 105,000 | — | $0 | 105,000 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2023-06-08 | 2023-06-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-05-16 | 2023-05-18 | 40,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-05-16 | 2023-05-18 | 40,000 | $25.00 | $1.00M | 30,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-05-16 | 2023-05-18 | 40,000 | $1.08 | $43.2K | 70,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-04 | 22,000 | — | $0 | 22,000 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2022-09-19 | 2022-09-20 | 15,750 | $5.26 | $82.8K | 191,797 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2022-09-16 | 2022-09-19 | 33,481 | $5.48 | $183.5K | 176,047 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2022-09-15 | 2022-09-19 | 17,147 | $5.41 | $92.8K | 142,566 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2022-09-14 | 2022-09-15 | 5,600 | $5.30 | $29.7K | 125,419 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2022-09-13 | 2022-09-15 | 18,784 | $5.20 | $97.7K | 119,819 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2022-08-01 | 2022-08-03 | 8,496 | $0.18 | $1.5K | 15,277 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2022-06-09 | 2022-06-13 | 19,200 | — | $0 | 19,200 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2022-06-07 | 2022-06-08 | 46,000 | — | $0 | 46,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 22,000 | — | $0 | 22,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2021-08-02 | 2021-08-04 | 777 | $1.20 | $932 | 23,773 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2021-07-28 | 2021-07-30 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2021-07-28 | 2021-07-30 | 17,500 | — | $0 | 24,550 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2021-06-16 | 2021-06-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2021-06-09 | 2021-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2021-06-02 | 2021-06-04 | 4,500 | — | $0 | 4,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2021-06-02 | 2021-06-04 | 2,250 | — | $0 | 5,812 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2021-01-11 | 2021-01-13 | 20,408 | $24.50 | $500.0K | 101,035 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 22,000 | — | $0 | 22,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-12-17 | 2020-12-18 | 10,909 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-12-17 | 2020-12-18 | 10,909 | $19.53 | $213.1K | 14,471 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-12-17 | 2020-12-18 | 10,909 | $117.82 | $1.29M | 3,562 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-11-03 | 2020-11-04 | 5,522 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-11-03 | 2020-11-04 | 5,522 | $9.46 | $52.2K | 9,084 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-11-03 | 2020-11-04 | 100 | $100.48 | $10.0K | 8,984 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-11-03 | 2020-11-04 | 694 | $95.97 | $66.6K | 3,562 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-11-03 | 2020-11-04 | 4,728 | $99.10 | $468.5K | 4,256 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-11-02 | 2020-11-04 | 4,478 | — | $0 | 5,522 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-11-02 | 2020-11-04 | 4,478 | $9.46 | $42.4K | 8,040 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-11-02 | 2020-11-04 | 4,478 | $99.11 | $443.8K | 3,562 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2020-07-29 | 2020-07-31 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2020-07-29 | 2020-07-31 | 17,500 | — | $0 | 70,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2020-06-24 | 2020-06-26 | 4,500 | — | $0 | 4,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2020-06-24 | 2020-06-26 | 2,250 | — | $0 | 3,562 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-06-19 | 2020-06-23 | 1,312 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-06-19 | 2020-06-23 | 1,312 | — | $0 | 1,312 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2020-06-17 | 2020-06-19 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion deriv | 2020-06-16 | 2020-06-18 | 89,423 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion | 2020-06-16 | 2020-06-18 | 50,627 | — | $0 | 50,627 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2020-06-16 | 2020-06-18 | 30,000 | $19.00 | $570.0K | 80,627 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2020-06-11 | 2020-06-15 | 52,000 | — | $0 | 52,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2020-01-02 | 2020-01-03 | 22,000 | — | $0 | 22,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-07-31 | 2019-08-01 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-06-20 | 2019-06-24 | 11,818 | — | $0 | 10,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-20 | 2019-06-24 | 947 | $96.69 | $91.6K | 10,871 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-20 | 2019-06-24 | 9,271 | $94.83 | $879.2K | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-20 | 2019-06-24 | 1,600 | $96.08 | $153.7K | 9,271 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-06-20 | 2019-06-24 | 11,818 | $9.46 | $111.8K | 11,818 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2019-06-19 | 2019-06-20 | 1,312 | — | $0 | 1,312 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2019-06-19 | 2019-06-20 | 4,875 | — | $0 | 4,875 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2019-01-02 | 2019-01-03 | 22,000 | — | $0 | 22,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2018-12-24 | 2018-12-27 | 53,000 | $1.31 | $69.4K | 53,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-08-01 | 2018-08-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2018-06-21 | 2018-06-25 | 7,500 | — | $0 | 51,136 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | P Buy | 2018-05-29 | 2018-05-31 | 30,000 | $5.16 | $154.8K | 30,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-05-02 | 2018-05-04 | 29,000 | — | $0 | 29,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2018-01-02 | 2018-01-03 | 16,000 | — | $0 | 16,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2017-09-15 | 2017-09-19 | 10,100 | — | $0 | 10,100 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2017-07-01 | 2017-07-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-27 | 16,000 | — | $0 | 16,000 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-27 | 10,100 | — | $0 | 10,100 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2017-06-21 | 2017-06-23 | 10,909 | — | $0 | 43,636 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 10,000 | $8.57 | $85.7K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 17,000 | $13.00 | $221.0K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 10,000 | $11.38 | $113.8K | 0 | SEC↗ |
| BIND DNIB UNWIND, INC. | M Exercise deriv | 2016-08-26 | 2016-08-30 | 15,000 | — | $0 | 0 | SEC↗ |
| BIND DNIB UNWIND, INC. | M Exercise | 2016-08-26 | 2016-08-30 | 15,000 | $0.44 | $6.6K | 15,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2016-06-23 | 2016-06-27 | 10,909 | — | $0 | 32,727 | SEC↗ |
| BIND BIND Therapeutics, Inc | A Award deriv | 2016-06-21 | 2016-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | A Award deriv | 2016-05-26 | 2016-05-27 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BIND BIND Therapeutics, Inc | A Award deriv | 2015-06-09 | 2015-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | A Award deriv | 2015-05-28 | 2015-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | A Award deriv | 2014-09-24 | 2014-09-26 | 17,000 | — | $0 | 17,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 20,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 20,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 20,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2014-06-05 | 2014-06-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BIND BIND Therapeutics, Inc | A Award deriv | 2014-05-28 | 2014-05-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 15,756 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 32,516 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 52,593 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 13,714 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 50,000 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 40,261 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 40,261 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 27,265 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 35,723 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer deriv | 2014-01-24 | 2014-01-28 | 34,570 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | U Tender | 2014-01-24 | 2014-01-28 | 87,026 | $50.00 | $4.35M | 0 | SEC↗ |
| VPHM VIROPHARMA INC | A Award | 2014-01-24 | 2014-01-28 | 48,878 | — | $0 | 48,878 | SEC↗ |
| VPHM VIROPHARMA INC | D To issuer | 2014-01-24 | 2014-01-28 | 48,878 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 13,080 | — | $0 | 13,714 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 1,852 | — | $0 | 52,593 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 8,361 | — | $0 | 15,756 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2014-01-08 | 2014-01-10 | 5,460 | — | $0 | 0 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-08 | 2014-01-10 | 8,361 | $11.96 | $100.0K | 88,003 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-08 | 2014-01-10 | 1,852 | $13.50 | $25.0K | 87,584 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2014-01-08 | 2014-01-10 | 2,271 | $49.80 | $113.1K | 85,732 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2014-01-08 | 2014-01-10 | 2,773 | $49.80 | $138.1K | 79,642 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2014-01-08 | 2014-01-10 | 558 | $49.80 | $27.8K | 87,026 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-08 | 2014-01-10 | 13,080 | $8.86 | $115.9K | 82,415 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2014-01-08 | 2014-01-10 | 847 | $49.80 | $42.2K | 69,335 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2014-01-08 | 2014-01-10 | 5,460 | $5.91 | $32.3K | 70,182 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-27 | 2013-12-31 | 4,540 | — | $0 | 5,460 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-27 | 2013-12-31 | 4,540 | $5.91 | $26.8K | 65,426 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-27 | 2013-12-31 | 704 | $49.86 | $35.1K | 64,722 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-18 | 2013-12-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-18 | 2013-12-20 | 23,206 | — | $0 | 26,794 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2013-12-18 | 2013-12-20 | 15,800 | — | $0 | 24,117 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-18 | 2013-12-20 | 11,835 | $49.74 | $588.7K | 60,886 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-18 | 2013-12-20 | 15,800 | $11.96 | $189.0K | 52,809 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-18 | 2013-12-20 | 9,330 | $49.74 | $464.1K | 43,479 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-18 | 2013-12-20 | 10,000 | $5.91 | $59.1K | 53,479 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2013-12-18 | 2013-12-20 | 3,964 | $49.74 | $197.2K | 49,515 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2013-12-18 | 2013-12-20 | 23,206 | $8.86 | $205.6K | 72,721 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2013-06-10 | 2013-06-12 | 32,516 | — | $0 | 32,516 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2013-06-06 | 2013-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2013-06-06 | 2013-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2013-01-03 | 2013-01-07 | 34,570 | — | $0 | 34,570 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2012-06-04 | 2012-06-06 | 35,723 | — | $0 | 35,723 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-03-07 | 2012-03-09 | 25,083 | — | $0 | 39,917 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-03-07 | 2012-03-09 | 5,555 | — | $0 | 54,445 | SEC↗ |
| VPHM VIROPHARMA INC | F Tax w/h | 2012-03-07 | 2012-03-09 | 12,715 | $29.49 | $375.0K | 35,048 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-03-07 | 2012-03-09 | 25,083 | $11.96 | $300.0K | 42,208 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-03-07 | 2012-03-09 | 5,555 | $13.50 | $75.0K | 47,763 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-03-01 | 2012-03-05 | 10,000 | — | $0 | 20,000 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-03-01 | 2012-03-05 | 25,000 | — | $0 | 50,000 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-03-01 | 2012-03-05 | 35,000 | — | $0 | 65,000 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-03-01 | 2012-03-05 | 25,000 | $8.86 | $221.5K | 99,875 | SEC↗ |
| VPHM VIROPHARMA INC | S Sale | 2012-03-01 | 2012-03-05 | 12,750 | $32.11 | $409.4K | 17,125 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-03-01 | 2012-03-05 | 35,000 | $11.96 | $418.6K | 64,875 | SEC↗ |
| VPHM VIROPHARMA INC | S Sale | 2012-03-01 | 2012-03-05 | 70,000 | $32.12 | $2.25M | 29,875 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-03-01 | 2012-03-05 | 10,000 | $5.91 | $59.1K | 74,875 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2012-01-05 | 2012-01-06 | 27,265 | — | $0 | 27,265 | SEC↗ |